GSA CAPITAL PARTNERS LLP - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2022$275,000
-12.4%
517,806
+800.7%
0.04%0.0%
Q4 2019$314,000
+307.8%
57,488
+265.2%
0.04%
+270.0%
Q3 2019$77,000
-40.3%
15,742
-7.9%
0.01%
+42.9%
Q3 2018$129,000
-81.7%
17,100
-87.7%
0.01%
-80.0%
Q2 2018$704,000
+49.2%
139,500
+109.8%
0.04%
+20.7%
Q4 2017$472,000
-34.5%
66,500
-34.0%
0.03%
-40.8%
Q3 2017$721,000
+94.9%
100,800
+71.4%
0.05%
+104.2%
Q2 2017$370,00058,8000.02%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders